Coimmune, Inc.
Records under this name other than the patents Coimmune, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,022,731 | Centrifuge Vessels with a Center Mound and an Internal Elongate Tube Suitable for Live Cell Processing and Associated Systems and Methods Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 9,970,068 | Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides Lapsed on the fee record Ended May 15, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2026 | From the USPTO record |
| US 9,102,726 | Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same Term ended Term ended Mar 27, 2026 · From the USPTO record | Term ended | Term ended Mar 27, 2026 | From the USPTO record |
| US 8,672,879 | Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures Lapsed on the fee record Ended Mar 18, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2026 | From the USPTO record |
| US 8,658,771 | Humanized Antibodies Against Human Interferon-Alpha Lapsed on the fee record Ended Feb 25, 2026 · Medium confidence | Lapsed on the fee record | Ended Feb 25, 2026 | Medium confidence |
| US 11,248,209 | Mature Dendritic Cell Compositions and Methods for Culturing Same Lapsed on the fee record Ended Feb 15, 2026 · High confidence | Lapsed on the fee record | Ended Feb 15, 2026 | High confidence |
| US 8,822,223 | Mature Dendritic Cell Compositions and Methods for Culturing Same Term ended Term ended Feb 12, 2026 · Medium confidence | Term ended | Term ended Feb 12, 2026 | Medium confidence |
| US 9,879,053 | Strain-independent amplification of pathogens and vaccines thereto Term ended Term ended Jan 9, 2026 · From the USPTO record | Term ended | Term ended Jan 9, 2026 | From the USPTO record |
| US 10,184,108 | Mature Dendritic Cell Compositions and Methods for Culturing Same Term ended Term ended Oct 7, 2025 · Medium confidence | Term ended | Term ended Oct 7, 2025 | Medium confidence |
| US 7,785,583 | In situ maturation of dendritic cells Term ended Term ended Sep 1, 2025 · From the USPTO record | Term ended | Term ended Sep 1, 2025 | From the USPTO record |